Motif ID: RARG
Z-value: 1.450
Transcription factors associated with RARG:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
RARG | ENSG00000172819.12 | RARG |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RARG | hg19_v2_chr12_-_53625958_53626036 | 0.91 | 5.9e-10 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 8.7 | GO:0006218 | uridine catabolic process(GO:0006218) |
1.7 | 5.2 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
1.7 | 6.9 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.6 | 4.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
1.5 | 5.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
1.4 | 8.5 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
1.3 | 5.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.2 | 3.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) cellular alkene metabolic process(GO:0043449) |
1.0 | 3.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
1.0 | 7.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.0 | 2.9 | GO:0042938 | dipeptide transport(GO:0042938) |
1.0 | 3.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.9 | 4.4 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.9 | 19.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.9 | 2.6 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.8 | 4.1 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.8 | 0.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.7 | 2.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) meiotic recombination checkpoint(GO:0051598) |
0.7 | 7.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.7 | 2.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.7 | 2.1 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.7 | 2.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.7 | 2.1 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.7 | 1.3 | GO:1903224 | regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.7 | 2.0 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.6 | 1.9 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.6 | 5.8 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 1.9 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.6 | 1.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.6 | 1.8 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.6 | 2.9 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.6 | 1.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.6 | 4.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.6 | 1.7 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.6 | 5.8 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.6 | 1.7 | GO:0002856 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) insulin catabolic process(GO:1901143) |
0.6 | 2.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.6 | 1.7 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.6 | 4.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 1.6 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.5 | 5.8 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 2.1 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.5 | 1.5 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.5 | 1.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.5 | 2.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.5 | 2.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.5 | 1.8 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.5 | 2.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.5 | 2.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.4 | 1.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.4 | 1.7 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 3.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.4 | 2.2 | GO:0097021 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
0.4 | 3.9 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.4 | 2.5 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
0.4 | 5.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 3.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 2.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.4 | 1.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) fast-twitch skeletal muscle fiber contraction(GO:0031443) relaxation of skeletal muscle(GO:0090076) |
0.4 | 1.6 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.4 | 2.4 | GO:0030805 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
0.4 | 0.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 2.2 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.4 | 1.5 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.4 | 1.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.4 | 1.8 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.4 | 1.5 | GO:1901558 | response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.4 | 1.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.4 | 0.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 0.7 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.4 | 2.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 2.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.3 | 1.0 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.3 | 2.0 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.3 | 1.7 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.3 | 2.0 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 4.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 0.9 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.3 | 1.5 | GO:1902378 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.3 | 0.9 | GO:0021586 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.3 | 0.6 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.3 | 2.0 | GO:0070305 | response to cGMP(GO:0070305) |
0.3 | 1.4 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.3 | 2.6 | GO:0046886 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
0.3 | 2.5 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.3 | 0.8 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.3 | 1.7 | GO:0035803 | egg coat formation(GO:0035803) |
0.3 | 1.1 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.3 | 1.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 2.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 0.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.3 | 1.0 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.3 | 1.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 0.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.3 | 1.0 | GO:0070384 | Harderian gland development(GO:0070384) |
0.3 | 2.8 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.3 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 1.0 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.2 | 1.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.2 | 1.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 1.4 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.2 | 0.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.2 | 4.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 1.3 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.7 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 0.7 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.2 | 0.7 | GO:0001207 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.2 | 3.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 2.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 5.5 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.2 | 0.4 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.2 | 0.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 0.8 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.2 | 2.9 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.2 | 0.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 2.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 0.8 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.2 | 0.6 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.2 | 0.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 1.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 3.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 1.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 1.0 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.2 | 1.2 | GO:0015811 | L-cystine transport(GO:0015811) |
0.2 | 5.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.2 | 0.6 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.2 | 2.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 0.6 | GO:1903625 | L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.2 | 0.6 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.2 | 0.7 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.2 | 0.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.9 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 0.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 0.5 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.2 | 0.4 | GO:0048627 | myoblast development(GO:0048627) |
0.2 | 0.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 2.0 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 1.2 | GO:1903764 | cortical microtubule organization(GO:0043622) regulation of potassium ion export across plasma membrane(GO:1903764) |
0.2 | 0.4 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.2 | 0.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 0.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 1.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 1.4 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 0.7 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.2 | 0.7 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 2.5 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 1.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.6 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.2 | 1.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 3.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 6.7 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 0.9 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.2 | 0.5 | GO:0003285 | septum secundum development(GO:0003285) embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 4.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.8 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.2 | 1.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.6 | GO:1904647 | response to rotenone(GO:1904647) |
0.2 | 0.8 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.2 | 3.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 0.9 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
0.2 | 0.8 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 3.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.3 | GO:1901727 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.3 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.1 | 0.9 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 2.2 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.3 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.1 | 1.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 2.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 2.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.4 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.1 | 1.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.4 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.4 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 1.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.6 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.6 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.4 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.1 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.4 | GO:0050894 | determination of affect(GO:0050894) |
0.1 | 3.3 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.1 | 0.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 0.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 0.4 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.1 | 1.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 2.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 2.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.9 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.7 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.4 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.1 | 0.4 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.1 | 0.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.4 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.5 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.1 | 2.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 1.5 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 1.8 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 1.8 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.9 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 5.0 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.5 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.8 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 1.9 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.4 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.3 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.2 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.1 | 0.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 1.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 0.6 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.2 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 0.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 1.6 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 0.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 1.7 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 1.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.6 | GO:0006875 | cellular metal ion homeostasis(GO:0006875) |
0.1 | 1.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 2.6 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.7 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.6 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 1.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 3.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 1.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 7.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.6 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.1 | 1.5 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 1.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.1 | 0.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.4 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.3 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.1 | 1.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.9 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.4 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.1 | 0.2 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 1.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.2 | GO:0040010 | positive regulation of growth rate(GO:0040010) negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
0.1 | 0.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 2.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 2.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 1.0 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 1.3 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 1.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 2.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.3 | GO:0032845 | negative regulation of homeostatic process(GO:0032845) |
0.1 | 0.2 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.9 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 1.7 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.3 | GO:0002884 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.2 | GO:0018194 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.1 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 1.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 1.5 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 1.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 1.6 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.2 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.1 | 1.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 1.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.1 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.1 | 0.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.3 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.1 | 1.1 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 1.2 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 0.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.5 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.1 | 2.2 | GO:0060996 | dendritic spine development(GO:0060996) |
0.1 | 0.5 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.3 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 1.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.4 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.1 | 0.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.9 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.1 | 1.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 7.7 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.7 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 1.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.6 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.3 | GO:0032425 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
0.1 | 0.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.5 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 1.3 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.2 | GO:0042264 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.2 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.1 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.5 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 0.5 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 1.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 1.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.2 | GO:0090403 | optic cup formation involved in camera-type eye development(GO:0003408) oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.1 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.1 | 0.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 0.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 1.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.3 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 0.4 | GO:0040032 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.2 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
0.0 | 0.7 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.0 | 0.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.4 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.5 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.2 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.0 | 0.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.0 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.1 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.0 | 1.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.4 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.0 | 0.4 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 2.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.0 | 0.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.9 | GO:0032094 | response to food(GO:0032094) |
0.0 | 2.7 | GO:0051058 | negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 1.4 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.6 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.9 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 2.8 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.8 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.6 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.1 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.0 | 0.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 1.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 1.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 2.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.6 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.4 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 1.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.3 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 1.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 1.0 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.1 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.0 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 1.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.0 | 0.2 | GO:0003014 | renal system process(GO:0003014) |
0.0 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 1.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.4 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.2 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 1.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.0 | 1.0 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 2.2 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 1.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.2 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.0 | 3.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.2 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.0 | 0.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.5 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.2 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.0 | 0.1 | GO:0021539 | subthalamus development(GO:0021539) |
0.0 | 0.6 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.0 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.3 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 2.3 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.2 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.2 | GO:0032571 | response to vitamin K(GO:0032571) |
0.0 | 0.4 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.2 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.0 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.6 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.2 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.0 | 0.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.6 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.5 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.7 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.1 | GO:1902093 | germ-line stem cell population maintenance(GO:0030718) positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 1.0 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 1.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 4.1 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.0 | 0.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.4 | GO:0007519 | skeletal muscle tissue development(GO:0007519) skeletal muscle organ development(GO:0060538) |
0.0 | 0.5 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.7 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.2 | GO:0060754 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.5 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 1.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 0.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.3 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.4 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.0 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.0 | 1.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 1.4 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 1.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.0 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.5 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.2 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.5 | GO:0043368 | positive T cell selection(GO:0043368) |
0.0 | 0.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.4 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.0 | 0.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.9 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.2 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.3 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.3 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.0 | 0.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 1.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 1.7 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 2.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.0 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.0 | 0.2 | GO:0045926 | negative regulation of growth(GO:0045926) |
0.0 | 0.0 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.0 | 0.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.2 | GO:0007163 | establishment or maintenance of cell polarity(GO:0007163) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.4 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0090190 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.2 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.1 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.0 | 0.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.1 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.4 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.0 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.0 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.0 | 0.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.3 | GO:0061337 | cardiac conduction(GO:0061337) |
0.0 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.4 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.1 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.4 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 0.6 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 0.1 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.1 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.4 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.3 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.5 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.0 | 0.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.4 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.8 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.2 | 8.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.0 | 6.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.7 | 2.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.7 | 4.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.5 | 2.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.5 | 2.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 1.8 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.4 | 2.0 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.4 | 1.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.4 | 2.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.3 | 1.7 | GO:0032449 | CBM complex(GO:0032449) |
0.3 | 0.9 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.3 | 2.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 1.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.2 | 3.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.7 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.2 | 6.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 4.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 2.0 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 4.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 0.6 | GO:0098855 | HCN channel complex(GO:0098855) |
0.2 | 1.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 1.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 2.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 5.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 7.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 1.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 4.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 2.1 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 3.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 3.0 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 2.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 1.2 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 2.2 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.7 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 0.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.1 | 0.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 1.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.5 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 1.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 2.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.4 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.1 | 1.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 9.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.4 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 1.8 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.4 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 3.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 0.3 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
0.1 | 0.6 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 1.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.9 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 1.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 2.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 2.8 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 2.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 7.3 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.6 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 1.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.8 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 1.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.2 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 5.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 2.9 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.2 | GO:1990742 | microvesicle(GO:1990742) |
0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 3.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 6.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.2 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.1 | 0.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 0.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.1 | 5.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 4.4 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 2.4 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 7.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 4.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 2.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 3.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.8 | GO:0031430 | M band(GO:0031430) |
0.1 | 2.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 1.9 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 1.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 4.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 3.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 1.6 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 4.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0031906 | late endosome lumen(GO:0031906) |
0.0 | 0.8 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 1.0 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 1.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.0 | 3.6 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 2.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 2.5 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 4.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 2.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.4 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 3.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.1 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.9 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 1.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.1 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 3.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 9.4 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.8 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 1.5 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 4.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 2.4 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 7.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 3.4 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0043073 | female germ cell nucleus(GO:0001674) germ cell nucleus(GO:0043073) |
0.0 | 0.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 1.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.4 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.4 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 1.8 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 6.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.2 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 2.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 1.6 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 2.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 8.7 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 0.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 1.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.2 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 2.1 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.4 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 3.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.0 | GO:0018444 | translation release factor complex(GO:0018444) |
0.0 | 0.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 6.1 | GO:0070161 | anchoring junction(GO:0070161) |
0.0 | 1.3 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 1.0 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.0 | 1.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
2.0 | 8.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.7 | 8.7 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.7 | 5.2 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
1.2 | 6.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.1 | 5.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.9 | 4.7 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.9 | 2.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.9 | 2.6 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.8 | 4.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.8 | 4.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.8 | 2.3 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.7 | 7.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.7 | 2.8 | GO:0030395 | lactose binding(GO:0030395) |
0.7 | 2.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.6 | 2.6 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.6 | 5.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.6 | 5.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.6 | 4.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.6 | 1.7 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.5 | 1.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.5 | 2.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.4 | 1.8 | GO:0008431 | vitamin E binding(GO:0008431) |
0.4 | 1.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.4 | 4.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 1.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.4 | 2.8 | GO:1990254 | keratin filament binding(GO:1990254) |
0.4 | 3.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 1.1 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.4 | 2.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 1.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.4 | 2.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 1.0 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.3 | 2.0 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.3 | 1.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.3 | 1.3 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.3 | 1.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 0.9 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.3 | 1.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.9 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.3 | 0.9 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.3 | 2.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 0.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 1.1 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.3 | 0.8 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.3 | 2.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 1.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.3 | 1.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 1.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 1.0 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.2 | 1.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 1.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 1.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.7 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.2 | 0.7 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 4.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 0.9 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.2 | 3.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.2 | 1.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 1.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 0.8 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 1.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 5.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.6 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.2 | 1.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.2 | 1.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 1.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.2 | 2.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 1.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 2.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 0.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.2 | 1.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 2.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 1.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.2 | 1.6 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 0.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 1.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 1.0 | GO:0039552 | RIG-I binding(GO:0039552) |
0.2 | 0.5 | GO:0070984 | SET domain binding(GO:0070984) |
0.2 | 1.3 | GO:0005497 | androgen binding(GO:0005497) |
0.2 | 0.9 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 0.9 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.2 | 1.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 0.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 1.1 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.2 | 1.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 2.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 6.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 3.7 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 4.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.4 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.1 | 0.6 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.1 | 1.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.4 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.1 | 1.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 2.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 5.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.1 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.1 | 0.4 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.1 | 42.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 4.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 3.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 1.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 1.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 1.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.5 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 0.4 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.4 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.1 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 2.1 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 1.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.4 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.3 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.1 | 0.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 2.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.7 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 2.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.9 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.4 | GO:0004335 | galactokinase activity(GO:0004335) |
0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 9.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.4 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 2.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 2.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.3 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.1 | 3.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 2.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.3 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.1 | 1.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 2.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0017129 | triglyceride binding(GO:0017129) |
0.1 | 0.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 2.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.5 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 0.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.2 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.1 | 1.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 2.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 1.0 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.1 | 0.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 6.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 3.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.1 | 2.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 2.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 3.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 1.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 2.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.2 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.1 | 0.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.5 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 8.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 1.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 2.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 1.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.8 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 1.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 4.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 1.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.5 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.2 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.1 | 0.9 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.2 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 1.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 1.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 8.5 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 3.4 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 1.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.2 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
0.0 | 0.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 1.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 1.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.7 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 1.5 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 1.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 1.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.6 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.0 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 1.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 1.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 5.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 2.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 3.9 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 1.0 | GO:0005126 | cytokine receptor binding(GO:0005126) |
0.0 | 0.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.9 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 1.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.7 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 4.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.4 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 0.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.8 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 1.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 2.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.0 | 1.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 11.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 3.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 1.7 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 1.5 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.1 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
0.0 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 1.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.0 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 1.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 2.9 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.0 | 0.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 2.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 1.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 1.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.6 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.1 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.2 | GO:0019838 | growth factor binding(GO:0019838) |
0.0 | 0.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.4 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.4 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.0 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 7.2 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 7.6 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 21.1 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
0.2 | 9.3 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 15.6 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.2 | 8.7 | PID_RAS_PATHWAY | Regulation of Ras family activation |
0.2 | 9.2 | NABA_COLLAGENS | Genes encoding collagen proteins |
0.2 | 5.5 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
0.1 | 3.4 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
0.1 | 1.3 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.1 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 3.0 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 5.9 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 4.4 | PID_RHOA_PATHWAY | RhoA signaling pathway |
0.1 | 2.7 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.0 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 4.4 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.2 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.5 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
0.1 | 1.7 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
0.1 | 28.5 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.0 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
0.1 | 3.1 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.4 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.6 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
0.1 | 1.8 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.6 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.3 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.3 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
0.1 | 4.4 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
0.1 | 0.9 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
0.1 | 2.5 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.1 | 3.8 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.7 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.2 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
0.1 | 1.8 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 2.9 | PID_FOXO_PATHWAY | FoxO family signaling |
0.1 | 1.1 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.8 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
0.1 | 0.1 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
0.1 | 1.7 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.4 | PID_REELIN_PATHWAY | Reelin signaling pathway |
0.1 | 0.4 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.5 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.8 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
0.0 | 3.2 | PID_NOTCH_PATHWAY | Notch signaling pathway |
0.0 | 2.6 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.1 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
0.0 | 0.6 | PID_AVB3_OPN_PATHWAY | Osteopontin-mediated events |
0.0 | 0.7 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.6 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
0.0 | 0.4 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.9 | PID_CD8_TCR_DOWNSTREAM_PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.6 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 2.9 | PID_E2F_PATHWAY | E2F transcription factor network |
0.0 | 0.6 | PID_HIV_NEF_PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.5 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.6 | PID_ENDOTHELIN_PATHWAY | Endothelins |
0.0 | 1.3 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.4 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.5 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.3 | PID_ER_NONGENOMIC_PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 1.2 | PID_P53_REGULATION_PATHWAY | p53 pathway |
0.0 | 0.7 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.2 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.0 | 1.3 | PID_CDC42_PATHWAY | CDC42 signaling events |
0.0 | 1.6 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.6 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.5 | PID_FGF_PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID_BCR_5PATHWAY | BCR signaling pathway |
0.0 | 0.2 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
0.0 | 6.0 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.0 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.4 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.6 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
0.0 | 0.5 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.8 | PID_TCR_PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.7 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 11.2 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 8.3 | REACTOME_PYRIMIDINE_CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 1.9 | REACTOME_HYALURONAN_METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 3.1 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
0.3 | 10.9 | REACTOME_KINESINS | Genes involved in Kinesins |
0.3 | 7.2 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 3.0 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 2.8 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 2.3 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 4.0 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
0.2 | 4.9 | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 5.4 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 2.8 | REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.2 | 3.7 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 6.2 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
0.2 | 2.7 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 2.0 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 6.7 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 2.3 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 4.8 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 3.5 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 7.7 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.6 | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.8 | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 2.3 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.5 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.2 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
0.1 | 11.8 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 6.2 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.5 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.8 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 4.8 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.5 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 2.4 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.9 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.7 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.3 | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.9 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.8 | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.6 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.6 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 3.7 | REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 2.8 | REACTOME_RECYCLING_PATHWAY_OF_L1 | Genes involved in Recycling pathway of L1 |
0.1 | 3.5 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.6 | REACTOME_GAB1_SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 1.0 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.1 | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.1 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 2.1 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.5 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.9 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.7 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.3 | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 1.5 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
0.1 | 1.7 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.5 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.4 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 11.8 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.4 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.7 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 2.8 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
0.1 | 6.5 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 2.5 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
0.0 | 3.6 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.9 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 1.4 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.9 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.5 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 2.3 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.1 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 3.1 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 1.6 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.4 | REACTOME_MICRORNA_MIRNA_BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 3.1 | REACTOME_CELL_JUNCTION_ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.2 | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.9 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.8 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 5.7 | REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.4 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.7 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
0.0 | 1.4 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.9 | REACTOME_DAG_AND_IP3_SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 1.0 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.6 | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.5 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.4 | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.3 | REACTOME_INFLUENZA_LIFE_CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.9 | REACTOME_BETA_DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.4 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.1 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.8 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 2.2 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.4 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 1.2 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 2.1 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.3 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
0.0 | 0.5 | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.3 | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.2 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.3 | REACTOME_HDL_MEDIATED_LIPID_TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.1 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.8 | REACTOME_SIGNALING_BY_FGFR1_MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.7 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 1.8 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.8 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.7 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.3 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.3 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.3 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 1.2 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.4 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.3 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.2 | REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.3 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.4 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.1 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 1.1 | REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME_SIGNALING_BY_ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.4 | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.2 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME_OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.3 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.3 | REACTOME_SIGNALING_BY_SCF_KIT | Genes involved in Signaling by SCF-KIT |